PASSAGE OF A CAST OF THE BLADDER PER URETHRAM. [electronic resource]
By: Producer: 20110329Description: 122-3 p. digitalISSN:- 0007-1447
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.
-
141
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
by Legros, Laurence -
142
Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.
by Heiblig, Maël -
143
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
by Nicolini, Franck E -
144
The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
by Deau, Bénédicte -
145
Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid leukemia: Results with 24 months of follow-up.
by Cortes, Jorge E -
146
Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.
by Nicolini, Franck E -
147
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
by Rea, Delphine -
148
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
by Mahon, François-Xavier -
149
Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.
by Rousselot, Philippe -
150
Reply to J. Richter et al.
by Rousselot, Philippe -
151
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study.
by Nicolini, Franck E -
152
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
by Kizilors, Aytug -
153
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
by Kantarjian, Hagop M -
154
United States Department of Agriculture-Agricultural Research Service research on natural products for pest management.
by Duke, Stephen O -
155
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.
by Deininger, Michael W -
156
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition.
by Mitchell, Rebecca -
157
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.
by Nicolini, Franck E -
158
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.
by Lipton, Jeffrey H -
159
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
by Cortes, Jorge E -
160
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
by Zabriskie, Matthew S
PASSAGE OF A CAST OF THE BLADDER PER URETHRAM.
APA
Barlet J. M., . (20110329). PASSAGE OF A CAST OF THE BLADDER PER URETHRAM. : British medical journal.
Chicago
Barlet J M, . 20110329. PASSAGE OF A CAST OF THE BLADDER PER URETHRAM. : British medical journal.
Harvard
Barlet J. M., . (20110329). PASSAGE OF A CAST OF THE BLADDER PER URETHRAM. : British medical journal.
MLA
Barlet J M, . PASSAGE OF A CAST OF THE BLADDER PER URETHRAM. : British medical journal. 20110329.